Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
The June edition of our People Pathways newsletter is available to read here!
Featuring:
✅ One Nucleus upcoming courses
✅ Training Course Spotlight: Introduction to Drug Development
✅ Practical Application of Toxicology in Drug Development 2025
2025 marks a special milestone — CamRARE’s 10th anniversary. A decade of progress. A future of possibilities. Over the past decade, we have championed collaboration, amplified patient voices, and driven progress in rare disease research, policy, and innovation.
We are looking for a motivated and talented postdoctoral-level researcher with experience in genomic analyses to join the newly established Coorens group at EMBL-EBI. We study how normal cells in different tissues acquire somatic mutations, use mutations as inherent barcodes to study human development and the origins of cancer, and develop computational tools to analyse mutations in novel single-cell and spatial data.
Gastronomica, Pioneer Group’s cutting-edge food tech hub, was crowned winner of the Innovative Workplace Design award at the Property Week and Construction News Life Sciences & Research Clusters Awards.
The Awards celebrated excellence in real estate design and delivery across the life sciences and research sectors, with winners announced at a gala evening at the Hilton Bankside, London on 24 June 2025.
We’re looking for a Research Scientist to undertake collaborative research funded by the NIHR Health Protection Research Unit in Gastrointestinal Infections, based in the group of Professor Arjan Narbad in our Microbes and Food Safety Programme.
The role
Creative Biolabs stands as a powerhouse of antibody engineering expertise, whose end-to-end humanization platform is turning xenogeneic antibodies into preclinical frontrunners.
A Ludwig Cancer Research team has cracked a metabolic code tumors use to evade immune attack, unveiling a humanized antibody that reignites anti-cancer immunity in resistant liver cancers, which was published in Cancer Discovery. The CD36-blocking antibody PLT012 overcomes lipid-driven immunosuppression, which is a game-changer for tumors exploiting fatty microenvironments.
Mills & Reeve LLP are collaborating with HSBC Innovation Banking to host their next instalment of Liquid Life Sciences at the Mills & Reeve Cambridge office.
You can expect a selection of drinks (including non-alcoholic) and pizzas, as well as the usual lively discussions and opportunities to make connections in the life sciences community.
No parking is available on site, the nearest car parks are Cambridge Railway Station and Cambridge Leisure Park, both a 5 to 8 min walk.